Jun 30, 2021
By: Rounak Jain
Credit: BCCL
Signed an agreement with the Abu Dhabi National Oil Company to set up a petrochemicals plant in Ruwais, Abu Dhabi. The plant will manufacture chlor-alkali, ethylene dichloride and polyvinyl chloride (PVC).
Credit: BCCL
Reported a 23 percent decline in March 2021 quarter profit to ₹104 crore, below analyst expectations. Revenue fell 41 percent to ₹339 crore, year-on-year.
Credit: IRCTC
To collaborate for clinical trials of the antiviral drug Molnupiravir for treatment of mild COVID-19 infections. Trial expected to be done on 1,200 volunteer patients.
Credit: Pixabay
The Indian drug maker to help Moderna, Inc., the maker of mRNA-based Spikevax COVID-19 vaccine, with regulatory approvals.
Credit: Cipla
Vodafone Idea, SpiceJet, Dish TV India, Coffee Day Enterprises, IRCON International, Balu Forge Industries, Sadbhav Engineering, SREI Infrastructure Finance, BF Utilities.
Credit: Pixabay
To invest an additional $500 million (approx. ₹3,700 crore) in OneWeb, a UK-based satellite internet provider. This will take its stake to 39 percent, making it the largest shareholder.
Credit: BCCL
To create a carbon offset of 2.5 lakh tonnes over the next five years, with a target of 60,000 tonnes by the end of this year.
Credit: BCCL
Approved fundraising of ₹7,000 crore via equity shares and other instruments.
Credit: Indiabulls Housing Finance
Entered into an agreement with the Indian Navy to develop emerging technologies, including artificial intelligence, robotics and quantum computing.
Credit: Bharat Electronics
Reported a net profit of ₹314 crore in the March 2021 quarter, against a net loss of ₹41 crore a year ago. Revenue jumped by over 51 percent to ₹4,860 crore, year-on-year.
Credit: Ruchi Soya